170 related articles for article (PubMed ID: 32572057)
1. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells.
Xu Y; Afify SM; Du J; Liu B; Hassan G; Wang Q; Li H; Liu Y; Fu X; Zhu Z; Chen L; Seno M
Sci Rep; 2022 Jan; 12(1):347. PubMed ID: 35013447
[TBL] [Abstract][Full Text] [Related]
3. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
5. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.
Yang CF; Yang GD; Huang TJ; Li R; Chu QQ; Xu L; Wang MS; Cai MD; Zhong L; Wei HJ; Huang HB; Huang JL; Qian CN; Huang BJ
Oncogene; 2016 Jun; 35(26):3419-31. PubMed ID: 26568302
[TBL] [Abstract][Full Text] [Related]
6. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway.
Hassan G; Afify SM; Du J; Nawara HM; Sheta M; Monzur S; Zahra MH; Abu Quora HA; Mansour H; El-Ghlban S; Uesaki R; Seno A; Seno M
Biochem Biophys Res Commun; 2021 Oct; 583():49-55. PubMed ID: 34735879
[TBL] [Abstract][Full Text] [Related]
7. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
[TBL] [Abstract][Full Text] [Related]
8. [TNF-α activates PI3K/AKT pathway to promote proliferation of SW620
Dai L; Zhao X; Ma L; Li X; Zuo D; Li Y; Wei B; Sui Y; Xu F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):33-41. PubMed ID: 32314722
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of Dsg2 confered stem cells with malignancy through wnt/β-catenin signaling pathway.
Chen L; Liu Y; Xu Y; Afify SM; Gao A; Du J; Liu B; Fu X; Liu Y; Yan T; Zhu Z; Seno M
Exp Cell Res; 2023 Jan; 422(1):113416. PubMed ID: 36375513
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
11. A novel model of liver cancer stem cells developed from induced pluripotent stem cells.
Afify SM; Sanchez Calle A; Hassan G; Kumon K; Nawara HM; Zahra MH; Mansour HM; Khayrani AC; Alam MJ; Du J; Seno A; Iwasaki Y; Seno M
Br J Cancer; 2020 Apr; 122(9):1378-1390. PubMed ID: 32203212
[TBL] [Abstract][Full Text] [Related]
12. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.
Hassan G; Ohara T; Afify SM; Kumon K; Zahra MH; Fu X; Al Kadi M; Seno A; Salomon DS; Seno M
J Exp Clin Cancer Res; 2022 Jan; 41(1):29. PubMed ID: 35063003
[TBL] [Abstract][Full Text] [Related]
13. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.
Nishi M; Akutsu H; Kudoh A; Kimura H; Yamamoto N; Umezawa A; Lee SW; Ryo A
Oncotarget; 2014 Sep; 5(18):8665-80. PubMed ID: 25228591
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the PI3K/AKT and MAPK/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells.
Li J; Wang J; Xie D; Pei Q; Wan X; Xing HR; Ye T
Int J Biol Sci; 2021; 17(5):1191-1202. PubMed ID: 33867839
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
[TBL] [Abstract][Full Text] [Related]
16. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
[TBL] [Abstract][Full Text] [Related]
17. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
[TBL] [Abstract][Full Text] [Related]
18. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
19. The small molecule inhibitors PD0325091 and CHIR99021 reduce expression of pluripotency-related genes in putative porcine induced pluripotent stem cells.
Petkov S; Hyttel P; Niemann H
Cell Reprogram; 2014 Aug; 16(4):235-40. PubMed ID: 24960205
[TBL] [Abstract][Full Text] [Related]
20. Neuralized1a regulates asymmetric division in mouse Lewis lung carcinoma cells.
Kong L; Li J; Liu Y; Sun Z; Zhou S; Tang J; Ye T; Wang J; Rosie Xing H
Life Sci; 2018 Aug; 206():70-76. PubMed ID: 29782871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
